Durham、NCにおける肥満症の臨床試験
Durhamとその周辺地域（約30マイル以内）の拠点で、肥満症に関する20件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Tirzepatide in Obesity-Driven Endometrial Cancer
被験者募集中早期第1相
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10マイル先
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
被験者募集中
- University of North Carolina at Chapel Hill, Chapel Hill · 10マイル先
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
被験者募集中第3相
- Duke Children's Primary Care, Durham
- UNC Children's Hospital, Chapel Hill · 10マイル先
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
被験者募集中第3相
- UNC Eastowne Medical Office, Chapel Hill · 10マイル先
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
被験者募集中第3相
- University of North Carolina Medical Center, Chapel Hill · 10マイル先
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
被験者募集中第3相
- Velocity Clinical Research - Durham, Durham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
被験者募集中第3相
- AURORA-2 Clinical Site, Durham
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
被験者募集中第3相
- Duke University Health System, Durham
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
被験者募集中第3相健康なボランティア歓迎
- ACCOMPLISH-2 Research Site, Durham
Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors
被験者募集中
- University of North Carolina at Chapel Hill, Chapel Hill · 10マイル先
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
被験者募集中第3相
- Duke University, Durham
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
被験者募集中第3相
- ACCOMPLISH-1 Research Site, Durham
Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)
被験者募集中
- Duke Health Center Creekstone, Durham
- Duke Healthy Lifestyles Clinic, Durham
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
被験者募集中第2相
- Velocity Clinical Research - Durham, Durham
Optimizing Telehealth-delivery of a Weight Loss Intervention in Older Adults
被験者募集中
- UNC Center for Aging and Health, Chapel Hill · 10マイル先
ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
被験者募集中第1相
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10マイル先
Interscalene vs Phrenic-sparing Blocks in Obesity and Effect of Maximum Inspiratory Pressure
被験者募集中
- University of North Carolina Hospitals, Chapel Hill · 10マイル先
Inspiratory Pulmonary Rehabilitation for Children With Obesity and Asthma
被験者募集中
- Duke Healthy Lifestyles Clinic, Durham
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
被験者募集中第2相健康なボランティア歓迎
- Duke University (Asthma, Allergy and Airway Center), Durham
Investigating Whether Acute Elevation of Fatty Acid Levels Alters Cerebral Glucose Transport and Metabolism
被験者募集中第1/2相健康なボランティア歓迎
- Biomedical Research Imaging Center Marsico Hall (UNC), Chapel Hill · 10マイル先
- Clinical and Translational Research Center (CTRC) Burnett-Womack Building (UNC), Chapel Hill · 10マイル先
他の都市における肥満症の試験
- Houston, TX43件の研究
- Chicago, IL41件の研究
- New York City, NY40件の研究
- San Antonio, TX40件の研究
- Washington, DC33件の研究
- Orlando, FL31件の研究
- Dallas, TX30件の研究
- Boston, MA28件の研究
- Las Vegas, NV27件の研究
- Miami, FL27件の研究
- Baltimore, MD25件の研究
- Jacksonville, FL25件の研究
Durhamにおける他の研究
- 乳がん63件の研究
- がん（全種類）58件の研究
- 非小細胞肺癌39件の研究
- 多発性骨髄腫37件の研究
- 転移性癌33件の研究
- 急性骨髄性白血病33件の研究
- 肺がん32件の研究
- 前立腺がん32件の研究
- 大腸癌28件の研究
- 慢性リンパ性白血病27件の研究
- 卵巣がん27件の研究
- 心不全26件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。